V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626063 | 330006414 | EXO | 3840 | null | 2 | 2016-10-25 | BUSULFAN | 330001621 | 330003190 | 330006414 |
| 16626064 | 330006415 | ECL02 | null | X292 | 1 | 2017-05-19 | NIVOLUMAB | 330001621 | 330003190 | 330006415 |
| 16626065 | 330006415 | ECL02 | 110 | x724 | 1 | 2017-05-20 | TOPOTECAN | 330001621 | 330003190 | 330006415 |
| 16626066 | 330006415 | EEI00 | 1.9 | X721 | 1 | 2017-05-20 | CARBOPLATIN | 330001621 | 330003190 | 330006415 |
| 16626067 | 330006415 | EPH | 50 | X724 | 2 | 2017-05-20 | DOXORUBICIN | 330001621 | 330003190 | 330006415 |
| 16626068 | 330006415 | EEI00 | 140 | X724 | 2 | 2017-05-21 | TRIAL | 330001621 | 330003190 | 330006415 |
| 16626069 | 330006419 | EEI00 | 180 | null | 1 | 2014-12-29 | GEMCITABINE | 330001661 | 330007706 | 330006419 |
| 16626070 | 330006419 | EUZ01 | 0.8 | x724 | 1 | 2014-12-30 | NOT CHEMO | 330001661 | 330007706 | 330006419 |
| 16626071 | 330006419 | EK1EN | 20 | X721 | 2 | 2014-12-30 | CETUXIMAB | 330001661 | 330007706 | 330006419 |
| 16626072 | 330006420 | EEI00 | 1400 | N/A | 1 | 2015-10-25 | MULTIPLE | 330001661 | 330007706 | 330006420 |
| 16626073 | 330006420 | E1UZ0 | 3.86 | X724 | 1 | 2015-10-26 | NOT CHEMO | 330001661 | 330007706 | 330006420 |
| 16626074 | 330006420 | E0N03 | 100 | X722 | 1 | 2015-10-26 | CETUXIMAB | 330001661 | 330007706 | 330006420 |
| 16626075 | 330006420 | EK1EN | 2800 | X724 | 1 | 2015-10-27 | ETOPOSIDE | 330001661 | 330007706 | 330006420 |
| 16626076 | 330006421 | EKA | 2640 | X724 | 1 | 2016-07-02 | AZACITIDINE | 330001661 | 330007706 | 330006421 |
| 16626077 | 330006422 | EKA | 150 | null | 1 | 2014-12-14 | CYTARABINE | 330001691 | 330003193 | 330006422 |
| 16626078 | 330006422 | EK1PP | 2750 | null | 1 | 2014-12-14 | DOXORUBICIN | 330001691 | 330003193 | 330006422 |
| 16626079 | 330006422 | EGU08 | 20 | null | 1 | 2014-12-15 | NOT CHEMO | 330001691 | 330003193 | 330006422 |
| 16626080 | 330006422 | E1UZ0 | 290 | X724 | 1 | 2014-12-16 | ETOPOSIDE | 330001691 | 330003193 | 330006422 |
| 16626081 | 330006422 | EEI00 | 50 | null | 5 | 2014-12-19 | DAUNORUBICIN | 330001691 | 330003193 | 330006422 |
| 16626082 | 330006422 | EE813 | 150 | X728 | 1 | 2014-12-19 | CARBOPLATIN | 330001691 | 330003193 | 330006422 |
| 16626083 | 330006423 | EGU08 | 4800 | null | 1 | 2014-07-10 | GANETESPIB | 330001697 | 330003195 | 330006423 |
| 16626084 | 330006427 | EJR | 150 | X723 | 1 | 2016-04-20 | CARBOPLATIN | 330001749 | 330003199 | 330006427 |
| 16626085 | 330006427 | EPH | 160 | X721 | 2 | 2016-04-20 | CETUXIMAB | 330001749 | 330003199 | 330006427 |
| 16626086 | 330006427 | EEI00 | 100 | X721 | 1 | 2016-04-20 | NOT CHEMO | 330001749 | 330003199 | 330006427 |
| 16626087 | 330006427 | EEI00 | 1 | X729 | 1 | 2016-04-21 | NOT CHEMO | 330001749 | 330003199 | 330006427 |
| 16626088 | 330006427 | EGU08 | null | X724 | 1 | 2016-04-21 | DACTINOMYCIN | 330001749 | 330003199 | 330006427 |
| 16626089 | 330006427 | ECL01 | 2320 | X721 | 2 | 2016-04-22 | AVELUMAB | 330001749 | 330003199 | 330006427 |
| 16626090 | 330006427 | EE813 | 150 | X721 | 1 | 2016-04-22 | IFOSFAMIDE | 330001749 | 330003199 | 330006427 |
| 16626091 | 330006428 | ED301 | 2750 | X721 | 1 | 2016-02-06 | VINCRISTINE | 330001765 | 330003200 | 330006428 |
| 16626092 | 330006428 | EUJ01 | 20 | X721 | 1 | 2016-02-06 | IFOSFAMIDE | 330001765 | 330003200 | 330006428 |
| 16626093 | 330006428 | EEI00 | 100 | null | 2 | 2016-02-06 | NOT CHEMO | 330001765 | 330003200 | 330006428 |
| 16626094 | 330006432 | EUZ | 2450 | null | 1 | 2017-07-16 | ETOPOSIDE | 330001791 | 330003205 | 330006432 |
| 16626095 | 330006432 | ECL01 | 20 | null | 1 | 2017-07-17 | IFOSFAMIDE | 330001791 | 330003205 | 330006432 |
| 16626096 | 330006432 | EKA | 1650 | null | 5 | 2017-07-17 | NOT CHEMO | 330001791 | 330003205 | 330006432 |
| 16626097 | 330006432 | EGU02 | 1400 | X724 | 1 | 2017-07-17 | AZD9150 | 330001791 | 330003205 | 330006432 |
| 16626098 | 330006435 | EEI00 | 160 | X731 | 1 | 2017-06-26 | CYCLOPHOSPHAMIDE | 330001814 | 330003207 | 330006435 |
| 16626099 | 330006435 | EPH | 1800 | X721 | 0 | 2017-06-27 | IFOSFAMIDE | 330001814 | 330003207 | 330006435 |
| 16626100 | 330006435 | EOF | 1400 | null | 1 | 2017-06-28 | TOPOTECAN | 330001814 | 330003207 | 330006435 |
| 16626101 | 330006437 | EQM | 300 | null | 1 | 2013-02-07 | TOPOTECAN | 330001822 | 330003210 | 330006437 |
| 16626102 | 330006437 | ECL01 | 100 | X721 | 2 | 2013-02-07 | ADI-PEG 20 | 330001822 | 330003210 | 330006437 |
| 16626103 | 330006443 | EQM | 10 | null | 1 | 2015-02-11 | DOXORUBICIN | 330001850 | 330007712 | 330006443 |
| 16626104 | 330006443 | ECL01 | 4800 | X721 | 2 | 2015-02-12 | TRIAL | 330001850 | 330007712 | 330006443 |
| 16626105 | 330006443 | EKA | 3040 | X721 | 1 | 2015-02-12 | TRIAL | 330001850 | 330007712 | 330006443 |
| 16626106 | 330006444 | ECL02 | 10 | null | 9 | 2016-03-23 | CYCLOPHOSPHAMIDE | 330001867 | 330012325 | 330006444 |
| 16626107 | 330006444 | EEI00 | 0 | X721 | 2 | 2016-03-23 | NOT CHEMO | 330001867 | 330012325 | 330006444 |
| 16626108 | 330006444 | ERA20 | 8 | X724 | 1 | 2016-03-24 | NOT CHEMO | 330001867 | 330012325 | 330006444 |
| 16626109 | 330006444 | EE813 | 8 | null | 1 | 2016-03-27 | NOT CHEMO | 330001867 | 330012325 | 330006444 |
| 16626110 | 330006444 | ECL01 | 110 | X724 | 1 | 2016-03-27 | BMS-986016 | 330001867 | 330012325 | 330006444 |
| 16626111 | 330006444 | E1UZ0 | 600 | null | 2 | 2016-03-27 | ETOPOSIDE | 330001867 | 330012325 | 330006444 |
| 16626112 | 330006444 | EEI00 | 290 | null | 1 | 2016-03-28 | IFOSFAMIDE | 330001867 | 330012325 | 330006444 |